Results 251 to 260 of about 12,288 (265)

Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial

Lancet Respiratory Medicine,the, 2023
Feng-Cai Zhu
exaly  

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

Lancet Infectious Diseases, The, 2022
Hongxing Pan, Minjie Li, Juan Yang
exaly  

Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study

Lancet Infectious Diseases, The, 2022
Eric Ho-Yin Lau, Peng Wu, Gabriel Leung
exaly  

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

Nature Medicine, 2021
Ana C Medeiros-Ribeiro, Nadia E Aikawa, Carla G Saad   +2 more
exaly  

Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study

EClinicalMedicine, 2022
Celine Sl Chui, Eric Yuk Fai Wan, Edmund Cheung   +2 more
exaly  

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

Lancet Infectious Diseases, The, 2021
Changgui Li, Qiang Gao
exaly  

An analysis of antibody response following the second dose of CoronaVac and humoral response after booster dose with BNT162b2 or CoronaVac among healthcare workers in Turkey

Journal of Medical Virology, 2022
Derya Caglayan, Ayca A Sayiner, Ozgur Appak   +2 more
exaly  

SAEs after BNT162b2, CoronaVac and ChAdOx1 vaccination

Reactions Weekly, 2022
openaire   +1 more source

Immunization related focal neurological syndrome after coronavac vaccination

Journal of the Neurological Sciences, 2021
Nijasri Suwanwela, Naruchorn Kijpaisalratana, Supatporn Tepmongkol, Pongpat Vorasayan, Chutibhorn Charnnarong, Jaturon Tantivatana, Wanakorn Rattanawong, Sirigunya Roongruang, Tatchaporn Ongphichetmetha, Wasan Akarathanawat, Aurauma Chutinet   +10 more
openaire   +1 more source

Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study

Lancet Infectious Diseases, The, 2022
Juan Pablo Torres
exaly